April, 2024
April 2024
OncoDaily Dialogues #3 – Andrés Wiernik / Hosted by Roupen Odabashian
Dec 4, 2023, 16:48

OncoDaily Dialogues #3 – Andrés Wiernik / Hosted by Roupen Odabashian

We continue our series of “OncoDaily Dialogues”. This effort by OncoDaily focuses on highlighting key figures in oncology, featuring their achievements, difficulties, and significant life learnings.

In this session, we’re privileged to welcome a distinguished oncologist from Costa Rica, professor Andrés Wiernik, the CEO of the Hospital Metropolitano Costa Rica and the Medical Director of the Hospital Metropolitano Research Institute.

Dr. Wiernik is a specialist trained in Internal Medicine, Hematology, Medical Oncology and Bone Marrow Transplantation. He studied medicine at UCIMED Medical School (Costa Rica), carried out his training in internal medicine at the Hennepin Healthcare System (Minnesota, USA), and his specialization in Hematology, Oncology and Bone Marrow Transplants at the University of Minnesota. During his training, he completed internships and fellowships at Harvard University (USA), the Karolinska Cancer Center (Sweden), the University of Turin (Italy), and the Peter MacCallum Cancer Center (Australia).

From 2014 to 2017, he was a member of the board of the Minnesota Society of Clinical Oncology, and has been named as one of the ‘Best Doctors’ in the area of ​​Medical Oncology and Hematology of the State of Minnesota (2016, 2017 and 2018). He has also been selected as a “Rising Star” in the field (2018, 2019) by the Minneapolis-St Paul Magazine.

Dr. Wiernik is licensed to practice in the United States and holds Board Certifications in Internal Medicine, Hematology and Medical Oncology.

In addition to his administrative roles and specialist of the Cancer and Hematology Center of the Metropolitano Hospital, Dr. Wiernik continues to periodically treat patients at the Hennepin Healthcare System where he used to lead the Breast Cancer Committee. He is also an assistant professor of medicine at the University of Minnesota and UCIMED Medical School. His work as a teacher in the field has been recognized with a great number of awards.

Throughout his academic career he has published in prestigious medical journals. During his training at the University of Minnesota, he was the lead investigator in the development of an immunological therapy for the treatment of acute myeloid leukemia and myelodysplastic syndromes, which is currently under clinical trials.

Dr. Wiernik is a member of the College of Physicians and Surgeons of Costa Rica, and holds an MBA from Chicago Booth Business School. He is a member of the ASCO International Affairs Committee and ASCO’s International Quality Steering Group.

Our host is Dr. Roupen Odabashian, hematology/oncology fellow at Karmanos Cancer Institute in Detroit, USA. Beyond his clinical practice, Dr. Odabashian possesses an unwavering passion for delving into the intricacies of healthcare policy, regulations and Oncology. He understands the multifaceted nature of cancer as a medical condition and acknowledges the various stakeholders and regulatory bodies that influence the delivery and administration of cancer treatments. In alignment with this commitment, he has joined OncoDaily, where he plays a pivotal role in conducting interviews with Leaders of the Cancer world.

You may view the previous series through the link below:

OncoDaily Dialogues #1 – Harout Semerjian / Hosted by Roupen Odabashian

OncoDaily Dialogues #2 – Piotr Wysocki / Hosted by Roupen Odabashian